We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




3D-Printed Blood Vessels Could Improve Outcomes for Heart Bypass Patients

By HospiMedica International staff writers
Posted on 29 Jul 2024
Print article
Image: A 3D printed blood vessel. (Photo courtesy of N. Radacsi, University of Edinburgh)
Image: A 3D printed blood vessel. (Photo courtesy of N. Radacsi, University of Edinburgh)

Strong, flexible, gel-like tubes developed through innovative 3D printing technology could improve heart bypass surgery outcomes, replacing the human and synthetic veins currently used to divert blood flow, according to experts. The creation of synthetic vessels can reduce scarring, pain, and infection risks linked to the extraction of human veins in bypass procedures. These products could also address the shortcomings of small synthetic grafts, which often struggle to integrate into the body, according to research published in Advanced Materials Technologies.

A research team led by The University of Edinburgh’s School of Engineering (Edinburgh, UK) employed a two-stage technique, integrating a rotating spindle with a 3D printer to fabricate tubular grafts from a water-based gel. This printed graft was reinforced using a process known as electrospinning, which utilizes high voltage to produce extremely fine nanofibers, thus coating the artificial blood vessel with biodegradable polyester molecules. Tests have confirmed that these products match the strength of natural blood vessels. The grafts, adjustable in diameters from 1 to 40 mm, are versatile for various applications, and their flexibility facilitates easy integration into the human body, according to the team. Future research phases will test these synthetic blood vessels in animal studies, with subsequent human trials planned.

“The results from our research address a long-standing challenge in the field of vascular tissue engineering – to produce a conduit that has similar biomechanical properties to that of human veins,” said Dr. Norbert Radacsi, Principal investigator, School of Engineering, University of Edinburgh. “With continued support and collaboration, the vision of improved treatment options for patients with cardiovascular disease could become a reality.”

Related Links:
The University of Edinburgh’s School of Engineering

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Oscillation & Lung Expansion Therapy System
Volara System
New
Hemodialysis Treatment System
Dialog+

Print article

Channels

Critical Care

view channel
Image: Artificial intelligence-derived intracranial pressure monitors vital information noninvasively (Photo courtesy of Icahn Mount Sinai)

AI-Driven Tool to Revolutionize Brain Pressure Monitoring in Intensive Care Patients

Intracranial hypertension, characterized by increased pressure within the brain, can lead to severe consequences such as strokes and hemorrhages. Traditionally, monitoring this condition requires invasive... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.